ClinicalTrials.gg
TerminatedNCT01747785X-HF-SPECKLEUpdated May 17, 2016

Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction

An observational study in Heart Failure, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-05-17.

Sponsored by Mayo Clinic · Observational

Why this study was terminated
Study stopped for administrative reasons.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
21
Ages
18 Years and older
Sex
All
01

Study summary

This study is being done to study how well the heart contracts and relaxes during exercise. In addition to traditional measures of heart function, we will use a new computer program that may improve understanding of why people feel shortness of breath or fatigue.

Read the detailed description

Heart failure with preserved ejection fraction is not well understood, although account for nearly half of all heart failure cases. This study aims to collect data about systolic (contracting portion of a heart beat) and diastolic (relaxing portion of a heart beat) dysfunction at rest and during exercise. Participants with normal cardiac function will serve as a control group and compared to participants who are at risk of heart failure.

02

Conditions studied

  • Heart Failure

Keywords

  • Heart failure
  • HFpEF
  • Dyspnea
  • Fatigue
  • Shortness of Breath
  • exercise
  • strain
  • myocardial deformation
  • cardiac rehabilitation
  • cardiac hemodynamics
03

In context

Heart Failure

5,803 studies on the registry are indexed under Heart Failure; 1,222 are open to participants now.

This study's enrollment of 21 is below the median of 200 across 1,719 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,263 studies on the registry; 670 are open to participants now.

Of its 450 completed or terminated interventional studies of FDA-regulated products, 318 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Community sample

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older,
  • able to exercise on a bicycle

Exclusion criteria

Exclusion Criteria:

  • heart arrhythmias,
  • severe chronic obstructive pulmonary disease,
  • congenital heart abnormalities,
  • infiltrative or hypertrophic cardiomyopathy.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
21 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy controls

    Individuals without history of cardiovascular disease and at least 18 years of age will take a baseline (at rest) cardiopulmonary exercise test (CPX) and have a cardiac echocardiogram to measure myocardial deformation. CPX and echocardiograms will be repeated during exercise sessions at 3 visits over a 12 week period.

    Other: Myocardial deformation imaging · Other: Cardiopulmonary exercise test

  • Patients at risk of heart failure

    Individuals at risk of heart failure and a preserved ejection fraction of at least 50% will take a baseline (at rest) cardiopulmonary exercise test (CPX) and have a baseline cardiac echocardiogram to measure myocardial deformation. CPX and echocardiograms will be repeated during exercise sessions at 6 visits over a 12 week period. A cardiac rehabilitation exercise program will also occur over 12 weeks.

    Other: Cardiac rehabilitation · Other: Myocardial deformation imaging · Other: Cardiopulmonary exercise test

Interventions

  • OtherCardiac rehabilitation

    Aerobic cardiac exercise training will be provided over the 12 week study duration.

  • OtherMyocardial deformation imaging

    A 2D Doppler echocardiograph (image) of the heart will be captured during a single heart beat taken at rest and during cardiopulmonary exercise tests to measure left and right ventricular segmental systolic and diastolic strain measurements.

  • OtherCardiopulmonary exercise test

    The cardiopulmonary exercise test consists of cycling exercise of mild and moderate intensity on an upright cycle ergometer on a tilting table (to facilitate imaging) for 6-10 minute periods within a one hour session.

06

What researchers measure

Primary outcomes

  1. Change in mean cardiac reserve as measured by strain rate

    Myocardial deformation imaging (e.g. strain, strain rate, torsion) requires clear 2-dimensional echocardiography images that will be obtain at rest and during mild and moderate intensity exercise. Images will be captured during 6-10 minute bouts of exercise on a tilting exercise table. Comparisons will be made on resting and exercise values between groups. Our hypothesis is that strain rate will not increase in patients at risk of heart failure demonstrating lack of cardiovascular reserve.

    Time frame: Baseline, 12 weeks

Secondary outcomes

  1. Change in mean cardiac stroke volume

    Stroke volume is the volume of blood (in milliliters) ejected during each heart contraction, It is measured by combined Doppler and 2-dimensional echocardiography. A surrogate measure of stroke volume (oxygen-pulse) can also be obtained during cardiopulmonary exercise testing by dividing the measured oxygen consumption by the heart rate. Our hypothesis is that stroke volume will plateau early after exercise onset in patients at risk of heart failure and this plateau will correlate with a reduction in strain rate.

    Time frame: Baseline, 12 weeks

07

Study locations

1 site
  • Mayo Clinic Health System - Franciscan Healthcare
    La Crosse, Wisconsin 54601, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01747785
Lead sponsor
Mayo Clinic
Responsible party
Hector R. Villarraga, M.D. (PI, Mayo Clinic) — Principal investigator
First posted
Dec 12, 2012
Start date
Jun 2012
Primary completion
Jul 2015
Completion
Jul 2015
Last update
May 17, 2016

Study contacts

Hector Villarraga, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion